Rockefeller Capital Management L.P. Karuna Therapeutics, Inc. Transaction History

Rockefeller Capital Management L.P.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Mar 06, 2023	SELL	$191.53 - $236.82 $766 - $947	-4 Reduced 17.39%	19 $3,000
Q3 2022 Nov 02, 2022	SELL	$123.79 - $277.42 $6,684 - $14,980	-54 Reduced 70.13%	23 $5,000
Q2 2022 Aug 12, 2022	BUY	$93.97 - $143.33 $5,450 - $8,313	58 Added 305.26%	77 $9,000
Q1 2022 May 13, 2022	BUY	$98.9 - $132.37 $593 - $794	6 Added 46.15%	19 $2,000
Q4 2021 Feb 14, 2022	BUY	$110.64 - $159.4 $1,438 - $2,072	13 New	13 $1,000
Q3 2021 Nov 12, 2021	SELL	$101.2 - $125.87 $910 - $1,132	-9 Closed	0 $0
Q2 2021 Aug 10, 2021	BUY	$107.45 - $135.95 $967 - $1,223	9 New	9 $1,000

332K

Ticker KRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,965,000
Description
Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...

Get notified when there are updates to the investment portfolio of Rockefeller Capital Management L.P., based on Form 13F filings with the SEC.

Stay updated on Rockefeller Capital Management L.P. with notifications on news.